Search
for
Sort by
Research 691–720 of 1000+
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Editorial: Targeted immunological therapies in dermatology
- Immune niches for hair follicle development and homeostasis
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Androgenetic alopecia: An update
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Skin Biology and Ageing
- Review of efficacy of baricitinib in the treatment of alopecia areata
- New Treatment Options for Alopecia Areata
- Dermatological diseases from a genetic perspective
- USE OF TOFACITINIB IN DIFFICULT TO TREAT CLINICALLY AMYOPATHIC DERMATOMYOSITIS
- Common Causes of Hair Loss
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- New Drugs for Alopecias
- Registrars and Fellows Update Session 2
- S3‐Leitlinie Diagnostik und Therapie der Alopecia areata – Teil 2: Therapie, psychosoziale und kosmetische Unterstützung
- Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey